List of Tables
Table 1. Global Humanized Bispecific Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Humanized Bispecific Antibodies Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Humanized Bispecific Antibodies Market Competitive Situation by Manufacturers in 2023
Table 4. Global Humanized Bispecific Antibodies Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Humanized Bispecific Antibodies Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Humanized Bispecific Antibodies Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Humanized Bispecific Antibodies Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Humanized Bispecific Antibodies Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Humanized Bispecific Antibodies, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Humanized Bispecific Antibodies, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Humanized Bispecific Antibodies, Product Type & Application
Table 12. Global Key Manufacturers of Humanized Bispecific Antibodies, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Humanized Bispecific Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humanized Bispecific Antibodies as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Humanized Bispecific Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Humanized Bispecific Antibodies Sales by Region (2019-2024) & (K Units)
Table 18. Global Humanized Bispecific Antibodies Sales Market Share by Region (2019-2024)
Table 19. Global Humanized Bispecific Antibodies Sales by Region (2025-2030) & (K Units)
Table 20. Global Humanized Bispecific Antibodies Sales Market Share by Region (2025-2030)
Table 21. Global Humanized Bispecific Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Humanized Bispecific Antibodies Revenue Market Share by Region (2019-2024)
Table 23. Global Humanized Bispecific Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Humanized Bispecific Antibodies Revenue Market Share by Region (2025-2030)
Table 25. North America Humanized Bispecific Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Humanized Bispecific Antibodies Sales by Country (2019-2024) & (K Units)
Table 27. North America Humanized Bispecific Antibodies Sales by Country (2025-2030) & (K Units)
Table 28. North America Humanized Bispecific Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Humanized Bispecific Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Humanized Bispecific Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Humanized Bispecific Antibodies Sales by Country (2019-2024) & (K Units)
Table 32. Europe Humanized Bispecific Antibodies Sales by Country (2025-2030) & (K Units)
Table 33. Europe Humanized Bispecific Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Humanized Bispecific Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Humanized Bispecific Antibodies Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Humanized Bispecific Antibodies Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Humanized Bispecific Antibodies Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Humanized Bispecific Antibodies Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Humanized Bispecific Antibodies Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Humanized Bispecific Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Humanized Bispecific Antibodies Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Humanized Bispecific Antibodies Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Humanized Bispecific Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Humanized Bispecific Antibodies Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Humanized Bispecific Antibodies Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Humanized Bispecific Antibodies Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Humanized Bispecific Antibodies Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Humanized Bispecific Antibodies Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Humanized Bispecific Antibodies Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Humanized Bispecific Antibodies Sales (K Units) by Type (2019-2024)
Table 51. Global Humanized Bispecific Antibodies Sales (K Units) by Type (2025-2030)
Table 52. Global Humanized Bispecific Antibodies Sales Market Share by Type (2019-2024)
Table 53. Global Humanized Bispecific Antibodies Sales Market Share by Type (2025-2030)
Table 54. Global Humanized Bispecific Antibodies Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Humanized Bispecific Antibodies Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Humanized Bispecific Antibodies Revenue Market Share by Type (2019-2024)
Table 57. Global Humanized Bispecific Antibodies Revenue Market Share by Type (2025-2030)
Table 58. Global Humanized Bispecific Antibodies Price (US$/Unit) by Type (2019-2024)
Table 59. Global Humanized Bispecific Antibodies Price (US$/Unit) by Type (2025-2030)
Table 60. Global Humanized Bispecific Antibodies Sales (K Units) by Application (2019-2024)
Table 61. Global Humanized Bispecific Antibodies Sales (K Units) by Application (2025-2030)
Table 62. Global Humanized Bispecific Antibodies Sales Market Share by Application (2019-2024)
Table 63. Global Humanized Bispecific Antibodies Sales Market Share by Application (2025-2030)
Table 64. Global Humanized Bispecific Antibodies Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Humanized Bispecific Antibodies Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Humanized Bispecific Antibodies Revenue Market Share by Application (2019-2024)
Table 67. Global Humanized Bispecific Antibodies Revenue Market Share by Application (2025-2030)
Table 68. Global Humanized Bispecific Antibodies Price (US$/Unit) by Application (2019-2024)
Table 69. Global Humanized Bispecific Antibodies Price (US$/Unit) by Application (2025-2030)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Humanized Bispecific Antibodies Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. AstraZeneca Company Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca Humanized Bispecific Antibodies Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. MacroGenics Company Information
Table 81. MacroGenics Description and Business Overview
Table 82. MacroGenics Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. MacroGenics Humanized Bispecific Antibodies Product
Table 84. MacroGenics Recent Developments/Updates
Table 85. Allist Company Information
Table 86. Allist Description and Business Overview
Table 87. Allist Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Allist Humanized Bispecific Antibodies Product
Table 89. Allist Recent Developments/Updates
Table 90. Genor Biopharma Company Information
Table 91. Genor Biopharma Description and Business Overview
Table 92. Genor Biopharma Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Genor Biopharma Humanized Bispecific Antibodies Product
Table 94. Genor Biopharma Recent Developments/Updates
Table 95. EpimAb Biotherapeutics Company Information
Table 96. EpimAb Biotherapeutics Description and Business Overview
Table 97. EpimAb Biotherapeutics Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. EpimAb Biotherapeutics Humanized Bispecific Antibodies Product
Table 99. EpimAb Biotherapeutics Recent Developments/Updates
Table 100. Betta Pharmaceuticals Company Information
Table 101. Betta Pharmaceuticals Description and Business Overview
Table 102. Betta Pharmaceuticals Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Betta Pharmaceuticals Humanized Bispecific Antibodies Product
Table 104. Betta Pharmaceuticals Recent Developments/Updates
Table 105. Tuowei Biotechnology Company Information
Table 106. Tuowei Biotechnology Description and Business Overview
Table 107. Tuowei Biotechnology Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Tuowei Biotechnology Humanized Bispecific Antibodies Product
Table 109. Tuowei Biotechnology Recent Developments/Updates
Table 110. Hansoh Pharmaceutical Company Information
Table 111. Hansoh Pharmaceutical Description and Business Overview
Table 112. Hansoh Pharmaceutical Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Hansoh Pharmaceutical Humanized Bispecific Antibodies Product
Table 114. Hansoh Pharmaceutical Recent Developments/Updates
Table 115. Biocytogen Co., Ltd. Company Information
Table 116. Biocytogen Co., Ltd. Description and Business Overview
Table 117. Biocytogen Co., Ltd. Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Biocytogen Co., Ltd. Humanized Bispecific Antibodies Product
Table 119. Biocytogen Co., Ltd. Recent Developments/Updates
Table 120. Doma Biopharmaceutical Company Information
Table 121. Doma Biopharmaceutical Description and Business Overview
Table 122. Doma Biopharmaceutical Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Doma Biopharmaceutical Humanized Bispecific Antibodies Product
Table 124. Doma Biopharmaceutical Recent Developments/Updates
Table 125. Dizal Pharma Company Information
Table 126. Dizal Pharma Description and Business Overview
Table 127. Dizal Pharma Humanized Bispecific Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Dizal Pharma Humanized Bispecific Antibodies Product
Table 129. Dizal Pharma Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Humanized Bispecific Antibodies Distributors List
Table 133. Humanized Bispecific Antibodies Customers List
Table 134. Humanized Bispecific Antibodies Market Trends
Table 135. Humanized Bispecific Antibodies Market Drivers
Table 136. Humanized Bispecific Antibodies Market Challenges
Table 137. Humanized Bispecific Antibodies Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Humanized Bispecific Antibodies
Figure 2. Global Humanized Bispecific Antibodies Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Humanized Bispecific Antibodies Market Share by Type: 2023 & 2030
Figure 4. IgG-like Double Antibody Product Picture
Figure 5. Fragmented Dual Antibody (FAD) Product Picture
Figure 6. Others Product Picture
Figure 7. Global Humanized Bispecific Antibodies Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Humanized Bispecific Antibodies Market Share by Application: 2023 & 2030
Figure 9. Oncology Treatment
Figure 10. Immune Disease Treatment
Figure 11. Infectious Disease Control
Figure 12. Others
Figure 13. Global Humanized Bispecific Antibodies Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Humanized Bispecific Antibodies Market Size (2019-2030) & (US$ Million)
Figure 15. Global Humanized Bispecific Antibodies Sales (2019-2030) & (K Units)
Figure 16. Global Humanized Bispecific Antibodies Average Price (US$/Unit) & (2019-2030)
Figure 17. Humanized Bispecific Antibodies Report Years Considered
Figure 18. Humanized Bispecific Antibodies Sales Share by Manufacturers in 2023
Figure 19. Global Humanized Bispecific Antibodies Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Humanized Bispecific Antibodies Players: Market Share by Revenue in Humanized Bispecific Antibodies in 2023
Figure 21. Humanized Bispecific Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Humanized Bispecific Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Humanized Bispecific Antibodies Sales Market Share by Country (2019-2030)
Figure 24. North America Humanized Bispecific Antibodies Revenue Market Share by Country (2019-2030)
Figure 25. United States Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Humanized Bispecific Antibodies Sales Market Share by Country (2019-2030)
Figure 28. Europe Humanized Bispecific Antibodies Revenue Market Share by Country (2019-2030)
Figure 29. Germany Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Humanized Bispecific Antibodies Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Humanized Bispecific Antibodies Revenue Market Share by Region (2019-2030)
Figure 36. China Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Humanized Bispecific Antibodies Sales Market Share by Country (2019-2030)
Figure 44. Mexico Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Humanized Bispecific Antibodies Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Humanized Bispecific Antibodies Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Humanized Bispecific Antibodies Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Humanized Bispecific Antibodies by Type (2019-2030)
Figure 54. Global Revenue Market Share of Humanized Bispecific Antibodies by Type (2019-2030)
Figure 55. Global Humanized Bispecific Antibodies Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Humanized Bispecific Antibodies by Application (2019-2030)
Figure 57. Global Revenue Market Share of Humanized Bispecific Antibodies by Application (2019-2030)
Figure 58. Global Humanized Bispecific Antibodies Price (US$/Unit) by Application (2019-2030)
Figure 59. Humanized Bispecific Antibodies Value Chain
Figure 60. Humanized Bispecific Antibodies Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
